MC
BMY icon

Mathes Company’s Bristol-Myers Squibb BMY Stock Holding History

Mathes Company’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,185
Closed -$422K – 114
2020
Q2 		$422K Buy
7,185
+560
+8% +$33.5K 0.21% 83
2020
Q1 		$369K Sell
6,625
-1,300
-16% -$79.5K 0.25% 80
2019
Q4 		$509K Sell
7,925
-10,934
-58% -$626K 0.24% 88
2019
Q3 		$956K Hold
18,859
– – 0.49% 60
2019
Q2 		$855K Buy
18,859
+12,900
+216% +$601K 0.45% 62
2019
Q1 		$284K Buy
5,959
+1,000
+20% +$49.8K 0.14% 107
2018
Q4 		$258K Hold
4,959
– – 0.16% 102
2018
Q3 		$308K Hold
4,959
– – 0.14% 107
2018
Q2 		$274K Hold
4,959
– – 0.13% 119
2018
Q1 		$314K Hold
4,959
– – 0.15% 109
2017
Q4 		$304K Hold
4,959
– – 0.14% 113
2017
Q3 		$316K Sell
4,959
-215
-4% -$12.6K 0.15% 116
2017
Q2 		$288K Hold
5,174
– – 0.14% 118
2017
Q1 		$281K Sell
5,174
-100
-2% -$5.49K 0.15% 110
2016
Q4 		$308K Sell
5,274
-28
-0.5% -$1.53K 0.17% 107
2016
Q3 		$286K Buy
5,302
+700
+15% +$45K 0.16% 106
2016
Q2 		$338K Sell
4,602
-41
-0.9% -$2.9K 0.2% 102
2016
Q1 		$297K Hold
4,643
– – 0.18% 104
2015
Q4 		$319K Sell
4,643
-1,000
-18% -$66.1K 0.18% 108
2015
Q3 		$334K Sell
5,643
-500
-8% -$31.7K 0.22% 96
2015
Q2 		$409K Sell
6,143
-300
-5% -$19.8K 0.22% 104
2015
Q1 		$416K Sell
6,443
-375
-6% -$23.5K 0.21% 114
2014
Q4 		$402K Sell
6,818
-2,090
-23% -$118K 0.21% 113
2014
Q3 		$456K Sell
8,908
-100
-1% -$5K 0.23% 110
2014
Q2 		$437K Sell
9,008
-400
-4% -$19.7K 0.22% 109
2014
Q1 		$489K Sell
9,408
-2,650
-22% -$141K 0.26% 103
2013
Q4 		$641K Buy
+12,058
New +$614K 0.34% 83

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Mathes Company's BMY Position: Q3 2020 in Review

Mathes Company sold out of Bristol-Myers Squibb (BMY) in Q3 2020, closing a stake of 7,185 shares — an estimated $422K sold.

Mathes Company first reported a position in BMY in Q4 2013 and held it in 27 quarters. The position peaked at $956K in Q3 2019. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

  • Mathes Company reported no remaining Bristol-Myers Squibb position as of Q3 2020 after selling out during the quarter.
  • Mathes Company sold 7,185 Bristol-Myers Squibb shares in Q3 2020, an estimated $422K.
  • Mathes Company first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 27 quarters.
  • Mathes Company's Bristol-Myers Squibb position peaked at $956K in Q3 2019.
  • 2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on Mathes Company's 13F filing for Q3 2020, filed 26 Oct 2020.